Evaluation of fasting state-/oral glucose tolerance test-derived measures of insulin release for the detection of genetically impaired β-cell function.
Evaluation of fasting state-/oral glucose tolerance test-derived measures of insulin release for the detection of genetically impaired β-cell function.
复制标题
DOI:
10.1371/journal.pone.0014194
复制
发表时间:
2010-12-02
期刊:
影响因子:
3.7
通讯作者:
Fritsche A
中科院分区:
文献类型:
--
作者:
Herzberg-Schäfer SA;Staiger H;Heni M;Ketterer C;Guthoff M;Kantartzis K;Machicao F;Stefan N;Häring HU;Fritsche A
To date, fasting state- and different oral glucose tolerance test (OGTT)-derived measures are used to estimate insulin release with reasonable effort in large human cohorts required, e.g., for genetic studies. Here, we evaluated twelve common (or recently introduced) fasting state-/OGTT-derived indices for their suitability to detect genetically determined β-cell dysfunction. A cohort of 1364 White European individuals at increased risk for type 2 diabetes was characterized by OGTT with glucose, insulin, and C-peptide measurements and genotyped for single nucleotide polymorphisms (SNPs) known to affect glucose- and incretin-stimulated insulin secretion. One fasting state- and eleven OGTT-derived indices were calculated and statistically evaluated. After adjustment for confounding variables, all tested SNPs were significantly associated with at least two insulin secretion measures (p≤0.05). The indices were ranked according to their associations' statistical power, and the ranks an index obtained for its associations with all the tested SNPs (or a subset) were summed up resulting in a final ranking. This approach revealed area under the curve (AUC)Insulin(0-30)/AUCGlucose(0-30) as the best-ranked index to detect SNP-dependent differences in insulin release. Moreover, AUCInsulin(0-30)/AUCGlucose(0-30), corrected insulin response (CIR), AUCC-Peptide(0-30)/AUCGlucose(0-30), AUCC-Peptide(0-120)/AUCGlucose(0-120), two different formulas for the incremental insulin response from 0–30 min, i.e., the insulinogenic indices (IGI)2 and IGI1, and insulin 30 min were significantly higher-ranked than homeostasis model assessment of β-cell function (HOMA-B; p<0.05). AUCC-Peptide(0-120)/AUCGlucose(0-120) was best-ranked for the detection of SNPs involved in incretin-stimulated insulin secretion. In all analyses, HOMA-β displayed the highest rank sums and, thus, scored last. With AUCInsulin(0-30)/AUCGlucose(0-30), CIR, AUCC-Peptide(0-30)/AUCGlucose(0-30), AUCC-Peptide(0-120)/AUCGlucose(0-120), IGI2, IGI1, and insulin 30 min, dynamic measures of insulin secretion based on early insulin and C-peptide responses to oral glucose represent measures which are more appropriate to assess genetically determined β-cell dysfunction than fasting measures, i.e., HOMA-B. Genes predominantly influencing the incretin axis may possibly be best detected by AUCC-Peptide(0-120)/AUCGlucose(0-120).
登录
查看更多内容
影响因子:
8.2
作者:
KADOWAKI, T;MIYAKE, Y;KOSAKA, K
通讯作者:
KOSAKA, K
影响因子:
3.7
作者:
Staiger, Harald;Machicao, Fausto;Kantartzis, Konstantinos;Schaefer, Silke A.;Kirchhoff, Kerstin;Guthoff, Martina;Silbernagel, Guenther;Stefan, Norbert;Fritsche, Andreas;Haering, Hans-Ulrich
通讯作者:
Haering, Hans-Ulrich
影响因子:
7.7
作者:
SLUITER, WJ;ERKELENS, DW;DOORENBOS, H
通讯作者:
DOORENBOS, H
影响因子:
16.2
作者:
Stumvoll, M;Mitrakou, A;Gerich, J
通讯作者:
Gerich, J
影响因子:
7.7
作者:
Müssig K;Staiger H;Machicao F;Kirchhoff K;Guthoff M;Schäfer SA;Kantartzis K;Silbernagel G;Stefan N;Holst JJ;Gallwitz B;Häring HU;Fritsche A
通讯作者:
Fritsche A